Biora Therapeutics Inc (BIOR)
0.73
-0.01
(-0.99%)
USD |
NASDAQ |
May 17, 16:00
0.73
0.00 (0.00%)
After-Hours: 20:00
Biora Therapeutics Total Assets (Quarterly): 31.22M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 31.22M |
September 30, 2023 | 34.70M |
June 30, 2023 | 49.67M |
March 31, 2023 | 53.24M |
December 31, 2022 | 53.52M |
September 30, 2022 | 62.61M |
June 30, 2022 | 77.10M |
March 31, 2022 | 86.74M |
December 31, 2021 | 108.84M |
Date | Value |
---|---|
September 30, 2021 | 97.68M |
June 30, 2021 | 119.95M |
March 31, 2021 | 128.58M |
December 31, 2020 | 154.44M |
September 30, 2020 | 119.62M |
June 30, 2020 | 186.42M |
March 31, 2020 | 110.95M |
December 31, 2019 | 101.73M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
31.22M
Minimum
Dec 2023
186.42M
Maximum
Jun 2020
92.77M
Average
97.68M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
Eiger BioPharmaceuticals Inc | 38.83M |
Disc Medicine Inc | 354.18M |
CEL-SCI Corp | 30.05M |
AIM ImmunoTech Inc | 19.38M |
IGC Pharma Inc | 11.26M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 132.64M |
Shareholders Equity (Quarterly) | -101.42M |